Biofrontera - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsBiofrontera

Biofrontera(BFRI)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aktipak	Erythromycin, Benzoyl peroxide	2000-11-27		Acne vulgaris , Bacterial infections , Gonorrhea , Campylobacter infections , Whooping cough , Chlamydia infections , Streptococcal infections , Legionnaires' disease , Urethritis , Bacterial eye infections , Syphilis , Staphylococcal infections , Mycoplasma infections , Protozoan infections , Gastroenteritis , Chancroid , Erythrasma , Rosacea
Ameluz	Aminolevulinic acid	2016-05-10	2028-2040	Actinic keratosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Aminolevulinic acid

,

head and neck neoplasms

,

skull base neoplasms

,

brain neoplasms

,

,

ovarian neoplasms

,

pituitary neoplasms

cardiovascular diseases

,

hypertriglyceridemia

actinic keratosis

,

,

,

uveal neoplasms

,

,

,

actinic keratosis

postoperative nausea and vomiting

,

,

viral hepatitis human

,

,

neurologic manifestations

,

brain neoplasms

,

,

,

biliary tract neoplasms

,

,

follicular lymphoma

,

,

squamous cell neoplasms

,

large cell carcinoma

,

chronic obstructive pulmonary disease

,

,

cholangiocarcinoma

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

b-cell lymphoma marginal zone

,

mantle-cell lymphoma

,

endometrial neoplasms

,

transitional cell carcinoma

,

uterine cervical neoplasms

,

type 2 diabetes mellitus

,

diabetes mellitus

,

non-small-cell lung carcinoma

,

,

,

,

breast neoplasms

,

,

communicable diseases

,

chronic hepatitis c

,

neoplasm metastasis

,

,

,

,

,

triple negative breast neoplasms

,

colorectal neoplasms

,

stomach neoplasms

,

esophageal neoplasms

,

,

head and neck neoplasms

,

ovarian neoplasms

,

,

chronic hepatitis

,

,

,

squamous cell carcinoma of head and neck

,

sleep initiation and maintenance disorders

,

clostridium infections

,

multiple myeloma

,

plasma cell neoplasms

,

squamous cell carcinoma

,

hodgkin disease

,

,

ovarian epithelial carcinoma

,

migraine disorders

,

castration-resistant prostatic neoplasms

,

pancreatic neoplasms

,

,

essential hypertension

,

nasopharyngeal neoplasms

,

acquired immunodeficiency syndrome

,

,

chronic renal insufficiency

,

kidney diseases

,

,

hepatocellular carcinoma

,

general anesthesia

,

neuromuscular blockade

,

intraabdominal infections

,

urinary tract infections

,

malignant mesothelioma

,

,

postmenopausal osteoporosis

,

hypercholesterolemia

,

alzheimer disease

,

,

erectile dysfunction

,

renal cell carcinoma

,

surgical wound infection

,

bacterial skin diseases

,

bacterial infections

,

staphylococcal infections

,

,

immunologic deficiency syndromes

,

urinary bladder neoplasms

,

,

type 1 diabetes mellitus

,

cytomegalovirus infections

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

allergic rhinitis

,

,

allergic rhinitis seasonal

,

liver neoplasms

,

fallopian tube neoplasms

,

,

,

bacterial pneumonia

,

,

,

,

,

hepatic insufficiency

,

,

prostatic hyperplasia

,

,

,

cognitive dysfunction

,

,

,

prostatic neoplasms

,

plexiform neurofibroma

,

neurofibromatosis 1

,

hereditary breast and ovarian cancer syndrome

,

,

central nervous system neoplasms

,

nervous system neoplasms

,

rheumatoid arthritis

,

,

hip osteoarthritis

,

surgical blood loss

,

replacement arthroplasty hip

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use